(2R,3R,3AS,9aR)-3-hydroxy-2-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one

Catalog No. :
ACJRXO576
CAS No. :
157024-76-5
Molecular Formula :
C14H18N2O6
Molecular Weight :
310.31

IUPAC Name:(2R,3R,3aS,9aR)-3-hydroxy-2-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one

(2R,3R,3AS,9aR)-3-hydroxy-2-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,3AS,9aR)-3-hydroxy-2-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one
IUPAC Name(2R,3R,3aS,9aR)-3-hydroxy-2-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one
Molecular FormulaC14H18N2O6
Molecular Weight310.31
SMILESO=C1N=C(O[C@]2([H])[C@@]3([H])O[C@H](COC4CCCCO4)[C@H]2O)N3C=C1
InChI KeyPWABFDWOJUOAKT-SLIWXIDXSA-N
Synonym6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]-, [2R-(2α,3β,3aβ,9aβ)]- (9CI)
CAS No.157024-76-5

Synthetic Route by SureRoute

1. ACJRXO576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQARB167 route compound structure diagram
    ACQARB1673736-77-4 In Stock
  4. Then
  5. ACJRXO576 route product structure diagram
    ACJRXO576157024-76-5
Inquiry

2. ACJRXO576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJRXO576 route product structure diagram
    ACJRXO576157024-76-5
Inquiry

Comments (0)